Expression of tumor-specific TCR allows CAR T-cells to directly identify the tumor antigen independently of major histocompatibility complex (MHC) and overcome some of the main mechanisms by which tumors can prevent MHC-based detection by T-cells [11,12]. Here, HLA-C is linked to neoplasm.